密歇根医学院可能会拒绝 7月1日开始的 密歇根州蓝十字蓝盾计划 Michigan Medicine may reject Blue Cross Blue Shield of Michigan plans starting July 1 over a reimbursement dispute.

密歇根医药公司警告说,由于在偿还率问题上的合同争议,它可能不再接受7月1日开始的密歇根州某些蓝十字蓝盾商业保险计划。 Michigan Medicine warns it may stop accepting certain Blue Cross Blue Shield of Michigan (BCBSM) commercial insurance plans starting July 1 due to a contract dispute over reimbursement rates. 医疗系统表示BCBSM的最新报价将减少30%的支付, 而BCBSM则声称密歇根医疗寻求44%的增长. The health system says BCBSM’s latest offer would cut payments by 30%, while BCBSM claims Michigan Medicine seeks a 44% increase. 一项为期120天的通知规定6月30日为新协定的最后期限。 A 120-day notice sets a June 30 deadline for a new agreement. 这场争端只影响到密歇根大学的学术医疗中心和附属医疗提供者,而不是UM-Health-Scarrow、UM-Health-West、或Medicare/Medicaid病人。 The dispute affects only the University of Michigan Health’s academic medical center and affiliated providers, not UM Health-Sparrow, UM Health-West, or Medicare/Medicaid patients. 密歇根医学院认为,与其他保险公司相比,它的工资过低,BCBSM的费率低22%,威胁着它提供高质量护理的能力。 Michigan Medicine argues it is underpaid compared to other insurers, with BCBSM rates 22% lower, threatening its ability to deliver high-quality care. 双方都说要避免中断,但是没有安排新的会谈。 Both sides say they want to avoid disruptions, but no new talks have been scheduled.